扩展前列腺磁共振成像报告以纳入基于临床风险计算器的诊断建议
文章讨论将临床风险计算器与多参数磁共振成像及前列腺影像报告和数据系统评分结合,用于前列腺癌风险分层;提出在磁共振报告中纳入风险计算器数据可拓宽放射科医生的作用、改善与临床医生的沟通,并帮助指导前列腺癌的筛查、检测和风险分层。
要点
- 风险计算器可弥补前列腺特异抗原筛查敏感度和特异度偏低的问题。
- 多参数磁共振成像与前列腺影像报告和数据系统评分使风险分层超出前列腺特异抗原和患者参数。
- 将风险计算器数据纳入前列腺磁共振报告可帮助指导前列腺癌筛查、检测和风险分层。
核心结论
- 将风险计算器数据纳入前列腺磁共振报告可拓宽放射科医生的作用、改善与临床医生的沟通,并帮助指导前列腺癌的筛查、检测和风险分层。
研究设计与样本
- 本文为发表于World J Radiol的指南类文章;原文未报告系统检索范围、纳入文献或证据分级方法。
临床应用与阅片要点
- 可将风险计算器数据纳入前列腺磁共振报告,以帮助指导前列腺癌的筛查、检测和风险分层。
- 低风险且未接受过活检的患者常接受不舒适、有创且可能不必要的前列腺活检。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Risk calculators have offered a viable tool for clinicians to stratify patients at risk of prostate cancer (PCa) and to mitigate the low sensitivity and specificity of screening prostate specific antigen (PSA). While initially based on clinical and demographic data, incorporation of multiparametric magnetic resonance imaging (MRI) and the validated prostate imaging reporting and data system suspicion scoring system has standardized and improved risk stratification beyond the use of PSA and patient parameters alone. Biopsy-naïve patients with lower risk profiles for harboring clinically significant PCa are often subjected to uncomfortable, invasive, and potentially unnecessary prostate biopsy procedures. Incorporating risk calculator data into prostate MRI reports can broaden the role of radiologists, improve communication with clinicians primarily managing these patients, and help guide clinical care in directing the screening, detection, and risk stratification of PCa.
引用
- Gupta K, Perchik JD, Fang AM, et al. Augmenting prostate magnetic resonance imaging reporting to incorporate diagnostic recommendations based upon clinical risk calculators. World J Radiol. 2022. PMID: 36160831. doi:10.4329/wjr.v14.i8.249
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。